BRIDGEWATER, N.J., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (OTCQB:VLRX) announced today that John Timberlake, President and Chief Executive Officer is scheduled to present at the Rodman & Renshaw 18 th Annual Global Investment Conference.
| Event: | Rodman & Renshaw 18 th Annual Global Investment Conference |
| Format: | Presentation and One-on-One Meetings |
| Date: | Tuesday, September 13, 2016 |
| Time: | 4:40pm EDT |
| Location: | New York, NY |
Audio webcasts of the Company’s presentation will be available by visiting the investor relations section of the Valeritas website at www.valeritas.com . Replays of the presentation will be available for 90 days.
Investors who are not attending the conference but would like to schedule a one-on-one meeting with Valeritas management may do so by contacting Joseph Green at The Ruth Group at jgreen@theruthgroup.com .
About Valeritas, Inc. Valeritas is a commercial-stage medical technology company focused on developing innovative technologies to improve the health and quality of life of people with Type 2 diabetes. Valeritas' flagship product, V-Go ® Disposable Insulin Delivery device, is a simple, wearable, basal-bolus insulin delivery solution for patients with Type 2 diabetes that enables patients to administer a continuous preset basal rate of insulin over 24 hours. It also provides on-demand bolus dosing at mealtimes. It is the only basal-bolus insulin delivery device on the market today specifically designed keeping in mind the needs of type 2 diabetes patients. Headquartered in Bridgewater, New Jersey, Valeritas operates its R&D functions in a state-of-the-art facility in Shrewsbury, Massachusetts. For more information, please visit www.valeritas.com .
Investor Contact: Nick Laudico / Zack Kubow The Ruth Group (646)536-7030 / 7020 IR@valeritas.com Media Contact: Christopher Hippolyte The Ruth Group (646)536-7023 PR@valeritas.com